As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through some executive moves from the first two mon
MariMed, Inc. (OTCQX: MRMD) announced its financial results Wednesday afternoon for the fourth quarter and full year ended December 31, 2022. The company reported sales for the year increased to $134 million, compared with $121.5 million the prior year.
MariMed (OTC:MRMD) reported quarterly earnings of $0.01 per share. This is a 150 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $35.83 million
MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator, announced it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC as the lead lender.
Federal prohibition makes it difficult for a cannabis business to operate fair and square. Not only is it depriving them from access to the financial system, but it also denies them the right to any U.S. federal income tax deduction for ordinary and necessary business expenses, despite being recognized as a legal business on the state level.